Sponsors (22)
The bill expands nationwide access to medication abortion via telehealth and mail-order under FDA authority, improving convenience and access for many patients while reducing state regulatory control and prompting legal, regulatory, and political conflicts.
Women seeking medication abortion — including people in rural areas and patients with chronic conditions — would retain and gain easier access to medication abortion via mail-order pharmacies and telehealth prescribing, reducing the need for in-person clinic visits.
State governments and health systems would operate under a single FDA-regulated national standard for medication abortion, reducing state-by-state variation and preserving federal regulatory authority.
Some state governments and taxpayers would face legal and political conflict because the bill limits state ability to enforce their own abortion regulations, likely producing litigation and associated costs.
Clinics, hospitals, and healthcare workers in states that oppose telehealth abortion would face regulatory uncertainty and increased risk of legal challenges when providing telehealth or mail-order medication abortion.
Opponents and some state officials may argue the reduction in state control undermines local public‑health oversight or additional safety requirements, producing political backlash.
Based on analysis of 1 section of legislative text.
Expresses that FDA approval of medication abortion preempts state laws requiring in‑person dispensing or banning/restricting telehealth prescribing/dispensing.
Declares that medication abortion is an FDA‑approved, extremely safe medical treatment and that FDA approval overrides State laws that require medication abortion to be given in person or that ban or limit prescribing/dispensing it via telehealth. The statement expresses a federal view that State restrictions of those two types are preempted by the FDA’s approval.
Official title: To express the Sense of Congress with respect to safety of medication abortion and Federal preemption of State restrictions on dispensing medication abortion, and for other purposes.
Introduced May 11, 2026 by Patrick Ryan · Last progress May 11, 2026